Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FLAT 15% MEDICARE REBATE FOR BRANDNAMES ADOPTED BY WAYS & MEANS COULD BE VIABLE, ATTRACTIVE ALTERNATIVE FOR BRAND FIRMS; PRYOR SEEKS 17% BRAND REBATES

Executive Summary

The 15% flat rebate for brandname products adopted by the House Ways & Means Committee on June 21 could cost the brandname sector as much as $11 bil. between 1997-2003 in rebates on drugs for the over-65 population but it also could create three major areas of savings for brand marketers.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024675

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel